Delirium, Dementia, Amnestic, Cognitive Disorders  >>  Byetta (exenatide)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Byetta (exenatide) / AstraZeneca
NCT01255163: A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease

Terminated
2
57
US
Exendin-4 SC, Exenatide SC, Placebo SC, Placebo SC twice daily
National Institute on Aging (NIA)
Alzheimer's Disease, Mild Cognitive Impairment
11/16
11/16

Download Options